Physician profile
Joan Kent
NPI 1144277112
$2,139.46
in general payments reported to CMS, 2019-2025
18 companies · $86.26 in 2025
The $86.26 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $79.12 · 2021: $36.50 · 2022: $401 · 2023: $169 · 2024: $937 · 2025: $86.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $789 · Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $788.69 |
| Food and Beverage | $403.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $788.69 | 2024 | |
| Abbvie INC. | $254.43 | 2019-2023 | |
| Pfizer INC. | $206.15 | 2019-2024 | |
| Astellas Pharma US INC | $184.37 | 2023-2025 | Veozah |
| Avion Pharmaceuticals | $135.67 | 2021-2023 | Balcoltra, Divigel |
| Vertical Pharmaceuticals, LLC | $111.32 | 2019 | |
| Amag Pharmaceuticals, INC. | $77.72 | 2019-2020 | |
| Therapeuticsmd, INC. | $61.67 | 2019-2022 | |
| Scynexis, INC. | $60.16 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.66 | 2025 | |
| Mycovia Pharmaceuticals, INC. | $38.47 | 2024 | Vivjoa |
| Allergan, INC. | $37.83 | 2019 | |
| Coopersurgical, INC. | $30.63 | 2019-2020 | |
| Myovant Sciences INC. | $26.08 | 2022 | |
| Millicent US INC | $24.94 | 2025 | Intrarosa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $24.09 | 2023 | Myfembree |
| Virtus Pharmaceuticals LLC | $19.80 | 2021 | |
| Hologic Sales and Service, LLC | $18.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Kent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.